Active Pharmaceutical Ingredient–our new study reveals trends, R&D progress, and predicted revenues
Where is the Active Pharmaceutical Ingredient market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 160+ page report provides 100+ tables and charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Active Pharmaceutical Ingredient Market. See how to exploit the opportunities.
Forecasts to 2030 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Global Active Pharmaceutical Ingredient Market by Synthesis
• Biotech
• Synthetic
Global Active Pharmaceutical Ingredient Market by Manufacturer
• Captive APIs
• Merchant APIs
Global Active Pharmaceutical Ingredient Market by API Type
• Generic APIs
• Innovative APIs
Global Active Pharmaceutical Ingredient Market by Application
• Cardiology
• Oncology
• CNS & Neurology
• Orthopedic
• Endocrinology
• Pulmonology
• Gastroenterology
• Nephrology
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets:
• North America:
• U.S.
• Canada
• Latin America:
• Brazil
• Mexico
• Rest of Latin America
• Europe:
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Asia-Pacific:
• Japan
• China
• India
• Australia
• ASEAN
• Rest of Asia-Pacific
• MEA:
• GCC Countries
• South Africa
• Rest of MEA
The report also includes profiles and for some of the leading companies in the Active Pharmaceutical Ingredient Market, with a focus on this segment of these companies’ operations.
There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, U.S., Germany, UK and India, China in particular, will continue to achieve high revenue growth to 2030.
Leading companies and the potential for market growth
Overall world revenue for Active Pharmaceutical Ingredient Market will surpass $175 billion in 2020, our work calculates. We predict strong revenue growth through to 2030.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Active Pharmaceutical Ingredient Market report helps you
In summary, our 160+ page report provides you with the following knowledge:
• Revenue forecasts to 2030 for Active Pharmaceutical Ingredient Market, with forecasts for Synthesis, Manufacturer, API Type, Application, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2030 for 5 regional and 17 key national markets – See forecasts for the Active Pharmaceutical Ingredient market in North America, Latin America, Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Russia, China, India, Japan, Australia, ASEAN countries, GCC Countries and South Africa.
• Prospects for established firms and those seeking to enter the market– including company profiles of the major companies involved in the Active Pharmaceutical Ingredient Market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the Active Pharmaceutical Ingredient Market and leading companies. You will find data, trends and predictions.
Buy our report today Active Pharmaceutical Ingredient Market Report 2020-2030: Forecasts by Synthesis (Biotech, Synthetic), by Manufacturer (Captive APIs, Merchant APIs), by API Type (Generic APIs, Innovative APIs), by Application (Cardiology, Oncology, CNS & Neurology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology), and Geography (North America, Latin America, Europe, Asia Pacific, MEA). Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Active Pharmaceutical Ingredient Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Global Active Pharmaceutical Ingredient Market Size and Forecast
2.3. Market Dynamics
2.3.1. Market Drivers
2.3.1.1. Increasing geriatric population
2.3.1.2. Rising preference for targeted therapy approach in cancer treatment
2.3.1.3. Increasing prevalence of target diseases such as hospital acquired infections, genetic, cardiovascular and neurological diseases
2.3.1.4. Increasing preference for outsourcing APIs
2.3.2. Market Restraints/Challenges
2.3.2.1. High capital investments and production cost
2.3.2.2. Stringent safety and handling regulations regarding APIs
2.3.2.3. Increasing penetration of counterfeit drugs
2.3.3. Opportunities
2.3.3.1. Highly potent active pharmaceutical ingredients
2.3.3.2. Emerging markets & technologies
2.3.4. Global Active Pharmaceutical Ingredient Market: Trends
2.3.5. Mergers and Acquisitions
2.3.6. Entry of New Market Players
2.4. SWOT Analysis
2.5. Porter’s Five Forces Analysis
2.6. PEST Analysis
2.7. COVID-19 Impact Analysis
2.7.1. Qualitative Analysis
2.7.2. Revenues & Forecast (Pre-COVID-19 v.s. Post-COVID-19)
2.7.3. Post COVID-19 Impact Analysis
2.7.3.1. V Shaped Recovery
2.7.3.2. U Shaped Recovery
2.7.3.3. L Shaped Recovery
2.7.3.4. W Shaped Recovery
2.7.4. Impact on Healthcare Industry
2.7.5. Impact of COVID-19 on GDP and Trade
3. Global Active Pharmaceutical Ingredient Market Analysis and Forecast, By Type of Synthesis
3.1. Introduction
3.1.1. Global Active Pharmaceutical Ingredient Market, Annual Growth Rate Comparison by Type of Synthesis
3.1.2. Global Active Pharmaceutical Ingredient Market Share Comparison by Type of Synthesis, (2020, 2025, 2030)
3.2. Global Active Pharmaceutical Ingredient Market Size and Forecast by Type of Synthesis
3.2.1. Biotech
3.2.2. Synthetic
3.3. Global Active Pharmaceutical Ingredient Attractiveness Index by Type of Synthesis
4. Global Active Pharmaceutical Ingredient Market Analysis and Forecast by Type of Manufacturer
4.1. Introduction
4.1.1. Global Active Pharmaceutical Ingredient Market, Annual Growth Rate Comparison by Type of Manufacturer
4.1.2. Global Active Pharmaceutical Ingredient Market Share Comparison by Type of Manufacturer, (2020, 2025, 2030)
4.2. Global Active Pharmaceutical Ingredient Market Size and Forecast by Type of Manufacturer
4.2.1. Captive APIs
4.2.2. Merchant APIs
4.3. Global Active Pharmaceutical Ingredient Attractiveness Index by Type of Manufacturer
5. Global Active Pharmaceutical Ingredient Market Analysis and Forecast by Type
5.1. Introduction
5.1.1. Global Active Pharmaceutical Ingredient Market, Annual Growth Rate Comparison by Type
5.1.2. Global Active Pharmaceutical Ingredient Market Share Comparison by Type, (2020, 2025, 2030)
5.2. Global Active Pharmaceutical Ingredient Market Size and Forecast by Type
5.2.1. Generic APIs
5.2.2. Innovative APIs
5.3. Global Active Pharmaceutical Ingredient Attractiveness Index by Type
6. Global Active Pharmaceutical Ingredient Market Analysis and Forecast by Application
6.1. Introduction
6.1.1. Global Active Pharmaceutical Ingredient Market, Annual Growth Rate Comparison by Application
6.1.2. Global Active Pharmaceutical Ingredient Market Share Comparison by Application, (2020, 2025, 2030)
6.2. Global Active Pharmaceutical Ingredient Market Size and Forecast by Application
6.2.1. Cardiology
6.2.2. Oncology
6.2.3. CNS & Neurology
6.2.4. Orthopedic
6.2.5. Endocrinology
6.2.6. Pulmonology
6.2.7. Gastroenterology
6.2.8. Nephrology
6.3. Global Active Pharmaceutical Ingredient Attractiveness Index by Application
7. Global Active Pharmaceutical Ingredient Market Analysis and Forecast by Region
7.1. Introduction
7.1.1. Global Active Pharmaceutical Ingredient Market, Annual Growth Rate Comparison by Region
7.1.2. Global Active Pharmaceutical Ingredient Market Share Comparison by Region (2020, 2025, 2030)
7.2. Global Active Pharmaceutical Ingredient Market Size and Forecast by Region
7.2.1. North America (U.S., Canada)
7.2.2. Latin America (Brazil, Mexico, Rest of Latin America)
7.2.3. Europe (UK, France, Germany, Italy, Spain, Russia, RoEU)
7.2.4. Asia Pacific (Japan, China, India, ASEAN, Australia, RoAPAC)
7.2.5. MEA (GCC, South Africa, RoMEA)
7.3. Global Active Pharmaceutical Ingredient Market Attractiveness Index by Region
8. North America Active Pharmaceutical Ingredient Market Analysis and Forecast, 2020-2030
8.1. Introduction
8.1.1. North America Active Pharmaceutical Ingredient Market
8.1.2. North America Active Pharmaceutical Ingredient Market, Annual Growth Rate Comparison by Country
8.2. North America Active Pharmaceutical Ingredient Market Size and Forecast by Country
8.2.1. The U.S. Active Pharmaceutical Ingredient Market
8.2.2. Canada Active Pharmaceutical Ingredient Market
8.3. North America Active Pharmaceutical Ingredient Market Size and Forecast by Type of Synthesis
8.4. North America Active Pharmaceutical Ingredient Market Size and Forecast by Type of Manufacturer
8.5. North America Active Pharmaceutical Ingredient Market Size and Forecast by Type
8.6. North America Active Pharmaceutical Ingredient Market Size and Forecast by Application
8.7. North America Active Pharmaceutical Ingredient Market Attractiveness Index by Country
9. Latin America Active Pharmaceutical Ingredient Market Analysis and Forecast, 2020-2030
9.1. Introduction
9.1.1. Latin America Active Pharmaceutical Ingredient Market
9.1.2. Latin America Active Pharmaceutical Ingredient Market, Annual Growth Rate Comparison by Country
9.2. Latin America Active Pharmaceutical Ingredient Market Size and Forecast by Country
9.2.1. Brazil Active Pharmaceutical Ingredient Market
9.2.2. Mexico Active Pharmaceutical Ingredient Market
9.2.3. Rest of Latin America Active Pharmaceutical Ingredient Market
9.3. Latin America Active Pharmaceutical Ingredient Market Size and Forecast by Type of Synthesis
9.4. Latin America Active Pharmaceutical Ingredient Market Size and Forecast by Type of Manufacturer
9.5. Latin America Active Pharmaceutical Ingredient Market Size and Forecast by Type
9.6. Latin America Active Pharmaceutical Ingredient Market Size and Forecast by Application
9.7. Latin America Active Pharmaceutical Ingredient Market Attractiveness Index by Country
10. Europe Active Pharmaceutical Ingredient Market Analysis and Forecast, 2020-2030
10.1. Introduction
10.1.1. Europe Active Pharmaceutical Ingredient Market
10.1.2. Europe Active Pharmaceutical Ingredient Market, Annual Growth Rate Comparison by Country
10.2. Europe Active Pharmaceutical Ingredient Market Size and Forecast by Country
10.2.1. U.K. Active Pharmaceutical Ingredient Market
10.2.2. France Active Pharmaceutical Ingredient Market
10.2.3. Germany Active Pharmaceutical Ingredient Market
10.2.4. Italy Active Pharmaceutical Ingredient Market
10.2.5. Spain Active Pharmaceutical Ingredient Market
10.2.6. Russia Active Pharmaceutical Ingredient Market
10.2.7. Rest of Europe Active Pharmaceutical Ingredient Market
10.3. Europe Active Pharmaceutical Ingredient Market Size and Forecast by Type of Synthesis
10.4. Europe Active Pharmaceutical Ingredient Market Size and Forecast by Type of Manufacturer
10.5. Europe Active Pharmaceutical Ingredient Market Size and Forecast by Type
10.6. Europe Active Pharmaceutical Ingredient Market Size and Forecast by Application
10.7. Europe Active Pharmaceutical Ingredient Market Attractiveness Index by Country
11. Asia Pacific Active Pharmaceutical Ingredient Market Analysis and Forecast, 2020-2030
11.1. Introduction
11.1.1. Asia Pacific Active Pharmaceutical Ingredient Market
11.1.2. Asia Pacific Active Pharmaceutical Ingredient Market, Annual Growth Rate Comparison by Country
11.2. Asia Pacific Active Pharmaceutical Ingredient Market Size and Forecast by Country
11.2.1. China Active Pharmaceutical Ingredient Market
11.2.2. India Active Pharmaceutical Ingredient Market
11.2.3. Australia Active Pharmaceutical Ingredient Market
11.2.4. ASEAN Active Pharmaceutical Ingredient Market
11.2.5. Japan Active Pharmaceutical Ingredient Market
11.2.6. Rest of Asia Pacific Active Pharmaceutical Ingredient Market
11.3. Asia Pacific Active Pharmaceutical Ingredient Market Size and Forecast by Type of Synthesis
11.4. Asia Pacific Active Pharmaceutical Ingredient Market Size and Forecast by Type of Manufacturer
11.5. Asia Pacific Active Pharmaceutical Ingredient Market Size and Forecast by Type
11.6. Asia Pacific Active Pharmaceutical Ingredient Market Size and Forecast by Application
11.7. Asia Pacific Active Pharmaceutical Ingredient Market Attractiveness Index by Country
12. MEA Active Pharmaceutical Ingredient Market Analysis and Forecast, 2020-2030
12.1. Introduction
12.1.1. MEA Active Pharmaceutical Ingredient Market
12.1.2. MEA Active Pharmaceutical Ingredient Market, Annual Growth Rate Comparison by Country
12.2. MEA Active Pharmaceutical Ingredient Market Size and Forecast by Country
12.2.1. GCC Active Pharmaceutical Ingredient Market
12.2.2. South Africa Active Pharmaceutical Ingredient Market
12.2.3. Rest of MEA Active Pharmaceutical Ingredient Market
12.3. MEA Active Pharmaceutical Ingredient Market Size and Forecast by Type of Synthesis
12.4. MEA Active Pharmaceutical Ingredient Market Size and Forecast by Type of Manufacturer
12.5. MEA Active Pharmaceutical Ingredient Market Size and Forecast by Type
12.6. MEA Active Pharmaceutical Ingredient Market Size and Forecast by Application
12.7. MEA Active Pharmaceutical Ingredient Market Attractiveness Index by Country
13. Leading Companies in the Active Pharmaceutical Ingredient Market
13.1. Competition Dashboard
13.2. Company Share Analysis
13.3. Leading Players
13.4. Abbvie Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance (2015-2019)
13.4.4. Recent Initiatives
13.5. Astrazeneca
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance (2015-2019)
13.5.4. Recent Initiatives
13.6. Aurobindo Pharma
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance (2015-2019)
13.6.4. Recent Initiatives
13.7. Albemarle Corporation
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance (2015-2019)
13.7.4. Recent Initiatives
13.8. Boehringer Ingelheim
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance (2015-2019)
13.8.4. Recent Initiatives
13.9. Bristol-Myers Squibb
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance (2015-2019)
13.9.4. Recent Initiatives
13.10. Eli Lilly and Company
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance (2015-2019)
13.10.4. Recent Initiatives
13.11. F. Hoffmann-La Roche
13.11.1. Company Overview
13.11.2. Product Offerings
13.11.3. Financial Performance (2015-2019)
13.11.4. Recent Initiatives
13.12. Glaxosmithkline PLC
13.12.1. Company Overview
13.12.2. Product Offerings
13.12.3. Financial Performance (2015-2019)
13.12.4. Recent Initiatives
13.13. Merck & Co., Inc.
13.13.1. Company Overview
13.13.2. Product Offerings
13.13.3. Financial Performance (2015-2019)
13.13.4. Recent Initiatives
13.14. Mylan N.V.
13.14.1. Company Overview
13.14.2. Product Offerings
13.14.3. Financial Performance (2015-2019)
13.14.4. Recent Initiatives
13.15. Cipla Inc.
13.15.1. Company Overview
13.15.2. Product Offerings
13.15.3. Financial Performance (2015-2019)
13.15.4. Recent Initiatives
13.16. Novartis AG
13.16.1. Company Overview
13.16.2. Product Offerings
13.16.3. Financial Performance (2015-2019)
13.16.4. Recent Initiatives
13.17. Pfizer, Inc.
13.17.1. Company Overview
13.17.2. Product Offerings
13.17.3. Financial Performance (2015-2019)
13.17.4. Recent Initiatives
13.18. Sanofi
13.18.1. Company Overview
13.18.2. Product Offerings
13.18.3. Financial Performance (2015-2019)
13.18.4. Recent Initiatives
13.19. Teva Pharmaceutical Industries Ltd.
13.19.1. Company Overview
13.19.2. Product Offerings
13.19.3. Financial Performance (2015-2019)
13.19.4. Recent Initiatives
13.20. Sun Pharmaceutical Industries, Ltd.
13.20.1. Company Overview
13.20.2. Product Offerings
13.20.3. Financial Performance (2015-2019)
13.20.4. Recent Initiatives
13.21. Dr. Reddy’s Laboratories Ltd.
13.21.1. Company Overview
13.21.2. Product Offerings
13.21.3. Financial Performance (2015-2019)
13.21.4. Recent Initiatives
14. Conclusion
15. Glossary
16. Appendix
LIST OF TABLES
Table 1 Global Active Pharmaceutical Ingredient Market Size by Region, 2020-2030 (USD Mn, CAGR%)
Table 2 Global Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 3 Global Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 4 Global Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 5 Global Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 6 North America: Active Pharmaceutical Ingredient Market Size by Country, 2020-2030 (USD Mn, CAGR%)
Table 7 North America: Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 8 North America: Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 9 North America: Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 10 North America: Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 11 U.S. Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 12 U.S. Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 13 U.S. Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 14 U.S. Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 15 Canada Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 16 Canada Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 17 Canada Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 18 Canada Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 19 Latin America: Active Pharmaceutical Ingredient Market Size by Country, 2020-2030 (USD Mn, CAGR%)
Table 20 Latin America: Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 21 Latin America: Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 22 Latin America: Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 23 Latin America: Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 24 Brazil Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 25 Brazil Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 26 Brazil Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 27 Brazil Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 28 Mexico Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 29 Mexico Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 30 Mexico Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 31 Mexico Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 32 Rest of Latin America Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 33 Rest of Latin America Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 34 Rest of Latin America Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 35 Rest of Latin America Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 36 Europe: Active Pharmaceutical Ingredient Market Size by Country, 2020-2030 (USD Mn, CAGR%)
Table 37 Europe: Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 38 Europe: Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 39 Europe: Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 40 Europe: Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 41 Germany Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 42 Germany Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 43 Germany Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 44 Germany Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 45 UK Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 46 UK Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 47 UK Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 48 UK Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 49 France Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 50 France Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 51 France Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 52 France Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 53 Italy Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 54 Italy Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 55 Italy Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 56 Italy Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 57 Spain Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 58 Spain Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 59 Spain Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 60 Spain Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 61 Russia Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 62 Russia Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 63 Russia Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 64 Russia Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 65 Rest of Europe Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 66 Rest of Europe Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 67 Rest of Europe Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 68 Rest of Europe Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 69 APAC: Active Pharmaceutical Ingredient Market Size by Country, 2020-2030 (USD Mn, CAGR%)
Table 70 APAC: Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 71 APAC: Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 72 APAC: Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 73 APAC: Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 74 Japan Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 75 Japan Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 76 Japan Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 77 Japan Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 78 China Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 79 China Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 80 China Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 81 China Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 82 India Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 83 India Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 84 India Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 85 India Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 86 Australia Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 87 Australia Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 88 Australia Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 89 Australia Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 90 ASEAN Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 91 ASEAN Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 92 ASEAN Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 93 ASEAN Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 94 Rest of APAC Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 95 Rest of APAC Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 96 Rest of APAC Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 97 Rest of APAC Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 98 MEA: Active Pharmaceutical Ingredient Market Size by Country, 2020-2030 (USD Mn, CAGR%)
Table 99 MEA: Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 100 MEA: Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 101 MEA: Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 102 MEA: Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 103 GCC Countries Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 104 GCC Countries Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 105 GCC Countries Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 106 GCC Countries Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 107 South Africa Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 108 South Africa Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 109 South Africa Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 110 South Africa Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
Table 111 Rest of MEA Active Pharmaceutical Ingredient Market Size by Type of Synthesis, 2020-2030 (USD Mn, CAGR%)
Table 112 Rest of MEA Active Pharmaceutical Ingredient Market Size by Type of Manufacturer, 2020-2030 (USD Mn, CAGR%)
Table 113 Rest of MEA Active Pharmaceutical Ingredient Market Size by Type, 2020-2030 (USD Mn, CAGR%)
Table 114 Rest of MEA Active Pharmaceutical Ingredient Market Size by Application, 2020-2030 (USD Mn, CAGR%)
LIST OF FIGURES
Figure 1 Active Pharmaceutical Ingredient Market Segmentation
Figure 2 Drivers, Restraints, Opportunities, and Challenges in the Active Pharmaceutical Ingredient Market
Figure 3 Value Chain Analysis
Figure 4 Porter’s Five Forces Analysis
Figure 5 Global Active Pharmaceutical Ingredient Market by Type of Synthesis (2020-2030)
Figure 6 Global Active Pharmaceutical Ingredient Market by Type of Manufacturer (2020-2030)
Figure 7 Global Active Pharmaceutical Ingredient Market by Type (2020-2030)
Figure 8 Global Active Pharmaceutical Ingredient Market by Application (2020-2030)
Figure 9 Global Active Pharmaceutical Ingredient Market by Region
Figure 10 North America Active Pharmaceutical Ingredient Market Snapshot
Figure 11 U.S. Active Pharmaceutical Ingredient Market, 2020-2030 (USD Mn)
Figure 12 Canada Active Pharmaceutical Ingredient Market, 2020-2030 (USD Mn)
Figure 13 Europe Active Pharmaceutical Ingredient Market Snapshot
Figure 14 Germany Active Pharmaceutical Ingredient Market, 2020-2030 (USD Mn)
Figure 15 France Active Pharmaceutical Ingredient Market, 2020-2030 (USD Mn)
Figure 16 UK Active Pharmaceutical Ingredient Market, 2020-2030 (USD Mn)
Figure 17 Italy Active Pharmaceutical Ingredient Market, 2020-2030 (USD Mn)
Figure 18 Spain Active Pharmaceutical Ingredient Market, 2020-2030 (USD Mn)
Figure 19 Russia Active Pharmaceutical Ingredient Market, 2020-2030 (USD Mn)
Figure 20 APAC Active Pharmaceutical Ingredient Market Snapshot
Figure 21 Japan Active Pharmaceutical Ingredient Market, 2020-2030 (USD Mn)
Figure 22 China Active Pharmaceutical Ingredient Market, 2020-2030 (USD Mn)
Figure 23 India Active Pharmaceutical Ingredient Market, 2020-2030 (USD Mn)
Figure 24 Australia Active Pharmaceutical Ingredient Market, 2020-2030 (USD Mn)
Figure 25 ASEAN Active Pharmaceutical Ingredient Market, 2020-2030 (USD Mn)
Figure 26 Latin America Active Pharmaceutical Ingredient Market Snapshot
Figure 27 Brazil Active Pharmaceutical Ingredient Market, 2020-2030 (USD Mn)
Figure 28 Mexico Active Pharmaceutical Ingredient Market, 2020-2030 (USD Mn)
Figure 29 MEA Active Pharmaceutical Ingredient Market Snapshot
Figure 30 GCC Countries Active Pharmaceutical Ingredient Market, 2020-2030 (USD Mn)
Figure 31 South Africa Active Pharmaceutical Ingredient Market, 2020-2030 (USD Mn)
Figure 32 Company Market Share Analysis
Figure 33 Abbvie Inc. Financial Snapshot
Figure 34 Astrazeneca Financial Snapshot
Figure 35 Aurobindo Pharma Financial Snapshot
Figure 36 Albemarle Corporation Financial Snapshot
Figure 37 Boehringer Ingelheim Financial Snapshot
Figure 38 Bristol-Myers Squibb Financial Snapshot
Figure 39 ELI Lilly and Company Financial Snapshot
Figure 40 F. Hoffmann-La Roche Financial Snapshot
Figure 41 Glaxosmithkline PLC Financial Snapshot
Figure 42 Merck & Co., Inc. Financial Snapshot
Figure 43 Mylan N.V. Financial Snapshot
Figure 44 Cipla Inc. Financial Snapshot
Figure 45 Novartis AG Financial Snapshot
Figure 46 Pfizer, Inc. Financial Snapshot
Figure 47 Sanofi Financial Snapshot
Figure 48 Teva Pharmaceutical Industries Ltd. Financial Snapshot
Figure 49 Sun Pharmaceutical Industries, Ltd. Financial Snapshot
Figure 50 Dr. Reddy’s Laboratories Ltd. Financial Snapshot